Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

Delayed Data
As of 4:00pm ET
 +1.04 / +2.20%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Arrowhead Pharmaceuticals Inc have a median target of 77.00, with a high estimate of 110.00 and a low estimate of 39.00. The median estimate represents a +59.32% increase from the last price of 48.33.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Arrowhead Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Dec 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 43.07%
Growthannually 4.17%


Growthquarterly 106.42%
Growthannually 97.62%
Key to the earnings and sales forecast charts.